Krajang Talabnin

4PUBLICATIONS
4CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 25, 2022
Inhibition of Ceramide Glycosylation Enhances Cisplatin Sensitivity in Cholangiocarcinoma by Limiting the Activation of the ERK Signaling Pathway.

Piyasiri Chueakwon, Peeranat Jatooratthawichot, Krajang Talabnin

|Feb 25, 2022
Down-Regulation of C1GALT1 Enhances the Progression of Cholangiocarcinoma through Activation of AKT/ERK Signaling Pathways.

Juthamas Khiaowichit, Chutima Talabnin, Chavaboon Dechsukhum

|Feb 04, 2021
High expression of tissue O-linked glycans is associated with a malignant phenotype of cholangiocarcinoma.

Krajang Talabnin, Chutima Talabnin, Juthamas Khiaowichit

|Jul 22, 2020
Ganglioside GM2: a potential biomarker for cholangiocarcinoma.

Krajang Talabnin, Chutima Talabnin, Tadahiro Kumagai

Pageof 1